Cancer Advisor

Keytruda - $29.5 billion Darzalex - $9 billion Opdivo - $7 billion Imbruvica - $5billion Tagrisso - $5 billion Revlimid - $4 billion Verzenio - $4 billion Imfinzi - $4 billion Ibrance - $3 billion Tecentriq - $3 billion In the rapidly evolving field of oncology, several cancer drugs have become best-sellers due to their proven effectiveness against various cancer types. Below, we examine some of the top-selling cancer drugs, highlighting their FDA-approved indications, mechanisms of action, and sales figures. 1. Keytruda (Pembrolizumab) - $29.5 billion Keytruda is the world's bestselling cancer drug by a large margin. (Merck & Co.) Company: Merck & Co. 2024 sales: $29.5 billion Indications Approved by FDA: Melanoma,  ( KEYNOTE-006 and KEYNOTE-054 trials) Non-small cell lung cancer,  ( KEYNOTE-010, KEYNOTE-407, KEYNOTE-189, KEYNOTE 671 trials) head and neck cancer,  ( KEYNOTE-012 and KEYNOTE-048) kidney cancer (renal cell carcinoma),  ( KEYNOTE-426) classical ...

Consider me your guide through the often confusing world of cancer prevention. Forget the jargon and the endless research papers – we're going to break down what really matters in simple, actionable steps you can take today. Think of this as your friendly handbook to boosting your body's natural defenses. Contents Why Prevention Matters (And Why You Don't Hear Enough About It) Navigating the Confusing World of Prevention Everyday Items, Extraordinary Potential Introducing the I-PREVENT CANCER Blueprint Real Strategies, Real Science Our Approach: Focusing on What Works Understanding the Evidence Pyramid What Exactly Is Cancer, and What Causes It? Diet and Cancer Prevention: Fueling Your Body's Defense 1. The American Cancer Society (ACS) 2020 Recommendation 2. A 2024 Update to International Guidelines 3. Avoid Processed Foods and Sugar: A Major Link to Risk 4. The Power of Plant-Based and Mediterranean Diets 5. The Importance of Dietary Fiber 6. Fasting, Low-Carb, and Ke...